De-identified Health Data Market, By Data Type, By Deployment Mode, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
De-identified Health Data Market size was valued at USD 7,549.09 Million in 2023, expanding at a CAGR of 9.20% from 2024 to 2032.
The de-identified health data market involves the collection, analysis, and sale of health data that has been stripped of personally identifiable information, ensuring patient confidentiality. As healthcare organizations increasingly seek insights from big data analytics to improve patient outcomes and operational efficiency, the demand for de-identified data is surging. Factors contributing to this growth include the rising emphasis on personalized medicine, which necessitates large datasets for effective analysis. Furthermore, initiatives promoting interoperability among health systems facilitate data sharing, enhancing the accessibility of de-identified health data. However, challenges such as data security concerns and regulatory compliance issues may hinder market growth. Opportunities exist in the expansion of artificial intelligence and machine learning technologies, which require extensive datasets for training algorithms. For instance, studies indicate that over 80% of healthcare providers plan to invest in analytics solutions by 2025, underscoring the increasing reliance on de-identified health data to drive innovation and improve healthcare delivery.
De-identified Health Data Market- Market Dynamics
Growing Focus on Personalized Medicine Drives Demand in the De-identified Health Data Market
The rising focus on personalized medicine is significantly propelling demand in the De-identified Health Data Market. As healthcare providers increasingly utilize patient data to tailor treatments, the need for de-identified health data has surged. According to a report from the U.S. Department of Health & Human Services, personalized medicine can lead to better patient outcomes and reduced healthcare costs. Additionally, initiatives like the All of Us Research Program aim to gather data from diverse populations to enhance individualized treatment approaches. Major tech firms, including IBM and Google, are investing in AI and analytics tools to leverage de-identified health data for research and clinical applications, facilitating advancements in personalized therapies. This growing trend highlights the critical role of secure and compliant data handling in improving healthcare services while maintaining patient privacy.
De-identified Health Data Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.20% over the forecast period (2024-2032)
Based on Data Type segmentation, Electronic Health Records was predicted to show maximum market share in the year 2023
Based on Deployment Mode segmentation, Cloud-Based was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
De-identified Health Data Market- Segmentation Analysis:
The Global De-identified Health Data Market is segmented on the basis of Data Type, Deployment Mode, Application, and Region.
The market is divided into four categories based on data type: electronic health records (EHR) are the highest priority due to their comprehensive patient information. Following closely are Claims Data, which provides insights into healthcare costs, Clinical Data, and Genomic Data, which offers specialized insights.
The market is divided into two categories based on Deployment Mode: On-Premise and Cloud-Based. Cloud-based deployment is prioritized due to its scalability and cost-effectiveness, allowing easier access to data. On-premise solutions follow, favored for enhanced security and control over sensitive health information, though they require more investment.
De-identified Health Data Market- Geographical Insights
In North America, the De-identified Health Data Market is led by the United States, which is home to numerous healthcare data companies and advanced analytics firms. The U.S. generated approximately $22 billion in health data revenue in 2022, showcasing the significant investment in data-driven healthcare solutions. In Europe, the market is growing due to the European Union's General Data Protection Regulation (GDPR), which encourages the responsible use of de-identified data, allowing countries like Germany and the UK to expand their healthcare analytics capabilities. Meanwhile, the Asia Pacific region is emerging as a strong contender, with countries like India and China focusing on digital health initiatives. India's healthcare IT sector is projected to grow to $9 billion by 2025, indicating a rising demand for de-identified health data. Latin America is also recognizing the importance of health data, with Brazil implementing health data laws that facilitate de-identified data use for public health improvements. These regional initiatives are reshaping the de-identified health data landscape globally.
De-identified Health Data Market- Competitive Landscape:
In the De-identified Health Data Market, North America remains the leading region, driven by technological advancements and robust healthcare systems. In January 2023, Optum, a health services company, announced a strategic partnership with a leading analytics firm to enhance its de-identified health data offerings, aiming to provide advanced insights to healthcare providers. Meanwhile, in Europe, a significant collaboration occurred in March 2023 between Siemens Healthineers and a European analytics company to leverage de-identified patient data for research purposes, enhancing patient outcomes. In the Asia Pacific, a notable merger took place in late 2022 when a prominent health tech startup acquired a local data analytics firm, expanding its capabilities in de-identified health data management. Additionally, the growth of the de-identified health data market is supported by favorable regulations, with the U.S. Office of the National Coordinator for Health Information Technology promoting the responsible use of health data. These developments reflect the competitive landscape's dynamic nature, emphasizing innovation and collaboration across the globe.
Recent Developments:
In February 2023, Mayo Clinic Platform and TripleBlind expanded their partnership to enhance de-identified data usage and patient privacy. This collaboration aims to improve global health outcomes by enabling secure data analysis without compromising patient information or intellectual property rights.
In April 2023, Philips and MIT's IMES enhanced the eICU Collaborative Research Database, providing researchers access to de-identified data from over 200,000 critical care patients. This initiative aims to advance AI in healthcare and improve clinical understanding and patient outcomes.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DE-IDENTIFIED HEALTH DATA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Aetion, Inc.
Agilent Technologies, Inc.
Allscripts Healthcare Solutions, Inc.
Cerner Corporation
Epic Systems Corporation
flatiron health, Inc.
GE Healthcare
IBM Watson Health
McKesson Corporation
Medidata Solutions, Inc.
Optum, Inc.
Oracle Corporation
Philips Healthcare
QuintilesIMS (IQVIA)
SAS Institute Inc.
Syapse, Inc.
Others
GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY DATA TYPE- MARKET ANALYSIS, 2019 - 2032
Electronic Health Records (EHR)
Claims Data
Clinical Data
Genomic Data
GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2019 - 2032
On-Premise
Cloud-Based
GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Healthcare Research
Patient Care
Population Health Management
Drug Development
GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
1. De-identified Health Data Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. De-identified Health Data Market Snippet by Data Type
2.1.2. De-identified Health Data Market Snippet by Deployment Mode
2.1.3. De-identified Health Data Market Snippet by Application
2.1.4. De-identified Health Data Market Snippet by Country
2.1.5. De-identified Health Data Market Snippet by Region
2.2. Competitive Insights
3. De-identified Health Data Key Market Trends
3.1. De-identified Health Data Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. De-identified Health Data Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. De-identified Health Data Market Opportunities
3.4. De-identified Health Data Market Future Trends
4. De-identified Health Data Industry Study
4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. De-identified Health Data Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. De-identified Health Data Market Landscape
6.1. De-identified Health Data Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players' Analysis
6.2.2. Emerging Players' Analysis
7. De-identified Health Data Market - By Data Type
7.1. Overview
7.1.1. Segment Share Analysis, By Data Type, 2023 & 2032 (%)
7.1.2. Electronic Health Records (EHR)
7.1.3. Claims Data
7.1.4. Clinical Data
7.1.5. Genomic Data
8. De-identified Health Data Market - By Deployment Mode